KilgourMD backs its claims with double-blind, third-party clinical testing. In an 8-week clinical evaluation of 32 participants experiencing mild to moderate thinning, subjects documented an average 30% reduction in hair shedding alongside noticeable improvements in individual strand thickness. Photographic reviews showed improved scalp coverage in crown and parting zones after four months of daily use.
However, clinical scrutiny requires putting these figures into perspective against established pharmaceutical baselines. While botanical serums produce meaningful gains for early thinning, their absolute efficacy operates on a different scale than FDA-cleared interventions.
| Treatment Modality | Active Mechanism | Average Clinical Shedding Drop | Monthly Cost & Texture Profile |
|---|---|---|---|
| KilgourMD Scalp Treatment | Botanical 5AR Blockers (EGCG, Saw Palmetto, Peptides) | 28%, 32% reduction within 60, 90 days | $65, $75 / month; Water-light, zero residue |
| Topical Minoxidil 5% | Potassium channel opener (vasodilation) | Causes temporary shedding spike, then 35% density gain | $15, $30 / month; Often greasy, risks flaking |
| Oral Finasteride (1mg) | Systemic Type II 5AR inhibition (cuts serum DHT ~70%) | Halts progression in 85%, 90% of men | $10, $25 / month; Pill form, systemic risk profile |
| Generic Rosemary Scalp Oils | Mild anti-inflammatory, minor circulation boost | Variable; no standardized clinical control | $10, $20 / month; Heavy oil, requires washing out |
